Title:
LIDOCAINE-CONTAINING PATCH
Document Type and Number:
WIPO Patent Application WO/2020/218249
Kind Code:
A1
Abstract:
This patch is bioequivalent to existing formulations even with higher concentrations of lidocaine, is highly safe, and contains lidocaine or a salt thereof, lactic acid, and hydroxy acid with 4-6 carbons; the skin penetration rate of the lidocaine when applying the patch to the skin is within an appropriate range, and the therapeutic effect of the lidocaine is exhibited persistently over a long period of time. The content of lactic acid is 0.6-1.2 mol per 1 mol of lidocaine or a salt thereof.
More Like This:
Inventors:
ISHIBASHI MASAKI (JP)
HAMAMOTO HIDETOSHI (JP)
HAMAMOTO HIDETOSHI (JP)
Application Number:
PCT/JP2020/017075
Publication Date:
October 29, 2020
Filing Date:
April 20, 2020
Export Citation:
Assignee:
MEDRX CO LTD (JP)
International Classes:
A61P23/02; A61K9/70; A61K31/167; A61K47/12; A61K47/14; A61K47/32
Domestic Patent References:
WO2013027840A1 | 2013-02-28 | |||
WO2013046335A1 | 2013-04-04 | |||
WO2012029097A1 | 2012-03-08 | |||
WO2009060629A1 | 2009-05-14 | |||
WO2018052039A1 | 2018-03-22 | |||
WO2009060629A1 | 2009-05-14 | |||
WO2018052039A1 | 2018-03-22 |
Foreign References:
JP2016003196A | 2016-01-12 | |||
JPH09110680A | 1997-04-28 |
Other References:
See also references of EP 3960238A4
Attorney, Agent or Firm:
YAMAO, Norihito et al. (JP)
Download PDF: